Induction of calcitonin receptor expression by glucocorticoids in T47D human breast cancer cells

J Endocrinol. 1991 Aug;130(2):321-6. doi: 10.1677/joe.0.1300321.

Abstract

When T47D cells were maintained long term in medium containing 0.1 mumol cortisol/l, calcitonin receptor (CTR) expression was stimulated compared with the very low levels of binding in untreated cells grown from frozen stocks. The time-course of the appearance of CTR following treatment with cortisol was slow, requiring up to 3 weeks of continuous exposure of the cells to the steroid. Binding capacity of control cells also increased slowly with time in culture, but after 3 months was only 20-30% of that in cells continuously treated with cortisol. Removal of cortisol resulted in rapid loss of CTR so that binding was reduced to approximately 50% of treated cell levels within 1 week of removal. Scatchard analysis of the binding data showed that the increased binding capacity induced by cortisol was due solely to a change in average receptor number per cell, with no change in receptor affinity. That this induction of CTR was due to a glucocorticoid effect was shown by the more rapid (less than 96 h) and more potent (less than 1 nmol/l) action of dexamethasone than of cortisol. In addition, induction was inhibited by the glucocorticoid inhibitor RU486. The induced receptors were shown to be functional, since salmon calcitonin-stimulated adenylate cyclase was induced in parallel with CTR. These results indicate that glucocorticoids are potential regulators of the CTR.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast Neoplasms / genetics
  • Breast Neoplasms / metabolism*
  • Calcitonin / genetics*
  • Carcinoma, Intraductal, Noninfiltrating / genetics
  • Carcinoma, Intraductal, Noninfiltrating / metabolism*
  • Cyclic AMP / metabolism
  • Dexamethasone / pharmacology
  • Female
  • Gene Expression Regulation / drug effects*
  • Humans
  • Hydrocortisone / pharmacology*
  • Mifepristone / pharmacology
  • Protein Binding / drug effects
  • Receptors, Calcitonin
  • Receptors, Cell Surface / genetics*
  • Time Factors
  • Tumor Cells, Cultured

Substances

  • Receptors, Calcitonin
  • Receptors, Cell Surface
  • Mifepristone
  • Dexamethasone
  • Calcitonin
  • Cyclic AMP
  • Hydrocortisone